HitGen has established an industry-leading drug discovery platform for small molecules and nucleic acid drugs centered on the design, synthesis and screening of DNA encoded chemical libraries (DELs), fragment-based drug discovery (FBDD) and structure-based drug design (SBDD) technologies. HitGen founder Dr. Jin Li and Vernalis chief scientist Professor Rod Hubbard will join hands to illustrate advancing innovative drug discovery by DNA Encoded Library and FBDD/SBDD methods. Register Today!